Comparison of the effect of calcium carbonate and calcium hydroxyapatite supplementation on the prognosis of pertrochanteric fracture surgery

Phase 3

Recruiting

• Conditions: Pertrochanteric Fracture.; Pertrochanteric fracture; S72.1

• Registration Number: IRCT20210712051854N1
• Lead Sponsor: Daroo Salamat Pharmed

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

All patients over 65 years referred to Trauma Emergency of Shariati Hospital with pertrochanteric fracture who are candidates for surgery

Exclusion Criteria

Patients who are not candidates for surgery due to medical problems with an ASA score of 3 or higher
Patients receiving osteoporosis treatments including bisphosphonates, calcium and vitamin D supplements, or hormone therapy prior to surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain Rate Score. Timepoint: Immediately after surgery, 3 months after surgery, 6 months after surgery. Method of measurement: Visual Analog Scale Questionnaire.;Bone Mineral Density. Timepoint: Immediately after surgery, 6 months after surgery. Method of measurement: Bone-marrow densitometry.;Fracture Union. Timepoint: Every month. Method of measurement: Radiography.

Secondary Outcome Measures

Name	Time	Method
Possible side effects of the drug. Timepoint: 3 months after surgery, 6 months after surgery. Method of measurement: Patient's Record and History.;Quadriceps Muscle Strength. Timepoint: After surgery, Third months follow-up, Sixth month follow-up. Method of measurement: Motor Function Measure.;Weight Bearing Time. Timepoint: 3 months after surgery, 6 months after surgery. Method of measurement: Patient's Record and History.